Haemonetics (HAE) Cash from Operations (2009 - 2026)

Haemonetics has reported Cash from Operations for 18 years, with the latest figure at $52.3 million in Q2 2026.

• On a quarterly basis, Cash from Operations rose 200.79% year-over-year to $52.3 million in Q2 2026; TTM through Jun 2026 was $328.1 million, a 44.85% increase from a year earlier, with the FY2026 full-year figure at $293.2 million, up 61.35% from the prior year.
• Cash from Operations was $52.3 million for Q2 2026 at Haemonetics, down from $70.9 million in the prior quarter.
• The five-year high for Cash from Operations was $116.6 million in Q1 2025, with the low at -$27.4 million in Q2 2024.
• Average Cash from Operations over 5 years is $58.6 million, with a median of $64.1 million recorded in 2024.
• The largest YoY upside for Cash from Operations was 8204.81% in 2024 against a maximum downside of 243.67% in 2024.
• Over 5 years, Cash from Operations stood at $64.4 million in 2022, then slumped by 100.84% to -$540000.0 in 2023, then jumped by 8204.81% to $43.8 million in 2024, then jumped by 113.78% to $93.6 million in 2025, then slumped by 44.08% to $52.3 million in 2026.
• The last three Cash from Operations figures came in at $52.3 million (Q2 2026), $70.9 million (Q1 2026), and $93.6 million (Q4 2025), per Business Quant data.